How many clinical trials are tracked of vehicle?

115 trials are tracked, 16 with published results.

Mode

All Infectious Disease Oncology Neurology Cardiology Psychiatry Diabetes & Endocrinology Pediatrics Allergy & Immunology Rheumatology Gastroenterology Primary Care & Family Medicine Nutrition & Obesity Medicine OB/GYN & Women's Health Orthopedics & Sports Medicine Genetics & Precision Medicine Radiology & Imaging Pulmonology & Critical Care Anesthesiology & Pain Medicine Physical Medicine & Rehab Nephrology Hematology Urology Dermatology Ophthalmology Emergency Medicine Geriatrics & Aging ENT (Otolaryngology) Palliative Care

Research

Clinical Trials Drug Pipeline Weekly Digests

Reference

Conditions Medications

Community

Questions

Text Size

vehicle

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials of vehicle

115 trials tracked of vehicle: 55 in phase 3 or 4 and 16 with published results. The most-cited published study has 281 citations.

115Trials tracked

55Phase 3 & 4

0Recruiting

16With published results

Phase distribution

Phase 4 5 Phase 3 50 Phase 2 57 Phase 1 3

Phase 3 Clobetasol Propionate Ophthalmic Nanoemulsion 0.05% for the Treatment of Inflammation and Pain Associated With Cataract Surgery (CLOSE-1) Completed · 281 cited
Phase 3 Clobetasol Propionate Ophthalmic Nanoemulsion 0.05% for the Treatment of Inflammation and Pain Associated With Cataract Surgery (CLOSE-2) Completed · 281 cited
Phase 3 Topical Ruxolitinib Evaluation in Vitiligo Study 2 (TRuE-V2) Completed · 263 cited
Phase 3 Topical Ruxolitinib Evaluation in Vitiligo Study 1 (TRuE-V1) Completed · 262 cited
Phase 3 Confirmatory Study of 17P vs Vehicle for Prevention of Preterm Birth in Women w/ Previous Spontaneous Preterm Delivery Completed · 229 cited
Phase 3 Evaluation of Efficacy and Safety of BF-200 ALA Used With Photodynamic Therapy in Patients With Actinic Keratosis. Completed · 124 cited

Show 44 more trials

Phase 3 LEO 90100 Compared to Vehicle in Subjects With Psoriasis Vulgaris Completed · 96 cited
Phase 3 A Study to Evaluate Long-Term Maintenance Treatment With Once Daily Crisaborole Ointment 2% in Pediatric and Adult Participants With Mild-to-Moderate Atopic Dermatitis Completed · 41 cited
Phase 3 Efficacy and Safety of Brimonidine Tartrate Ophthalmic Solution in Adult and Geriatric Participants With Ocular Redness Completed · 29 cited
Phase 3 This Trial is a Randomised, Multicentre, Investigator-blind, Vehicle and Comparator-controlled, Parallel-group Trial With the Purpose of Evaluation Efficacy, Safety and Convenience of the MC2-01 Cream Completed · 24 cited
Phase 3 Study Investigating the Safety and Efficacy of HP802-247 in the Treatment of Venous Leg Ulcers >12 cm2 to ≤ 36 cm2 Completed · 24 cited
Phase 3 An Evaluation of the Efficacy and Safety of CSF-1 in the Temporary Correction of Presbyopia (NEAR-2) Completed · 17 cited
Phase 3 An Evaluation of the Efficacy and Safety of CSF-1 in the Temporary Correction of Presbyopia (NEAR-1) Completed · 16 cited
Phase 3 A Study to Assess the Impact and Adverse Events of Topical Eyedrops of AGN-190584 on Night-driving Performance in Participants, 40 to 55 Years of Age Completed · 8 cited
Phase 3 Efficacy and Tolerance of Nova22007 Versus Vehicle in Patients With Vernal Keratoconjunctivitis (VKC) Completed · 7 cited
Phase 3 Assess the Long Term Efficacy and Safety of Ruxolitinib Cream in Participants With Vitiligo Completed · 4 cited
Phase 4 24-hr Intraocular Pressure Control With SIMBRINZA ® Completed
Phase 4 Efficacy and Safety of Enstilar Foam in Combination With Apremilast (Otezla) in Patients With Moderate Plaque Psoriasis Completed
Phase 4 Effect of SIMBRINZA® Suspension as an Added Therapy to a Prostaglandin Analogue Completed
Phase 4 Pediatric Zylet Safety and Efficacy Study Completed
Phase 4 Effect of SIMBRINZA® Suspension as an Added Therapy to TRAVATAN Z® Completed
Phase 3 Evaluation of Safety and Efficacy of BF-200 ALA for the Treatment of Actinic Keratosis With Photodynamic Therapy Completed
Phase 3 Efficacy and Safety of Brinzolamide/Brimonidine Fixed Combination BID Compared to Brinzolamide BID Plus Brimonidine BID in Subjects With Open-Angle Glaucoma (OAG) or Ocular Hypertension (OHT) Completed
Phase 3 Phase 2/3 Dose-Ranging Study of the Safety and Efficacy of OTX-101 in the Treatment of Keratoconjunctivitis Sicca Completed
Phase 3 Safety of Brimonidine Tartrate Ophthalmic Solution in a Population of Pediatric, Adult, and Geriatric Participants Completed
Phase 3 A Study to Evaluate the Safety and Clinical Study of Azelaic Acid Gel 15% in Patients With Moderate Facial Rosacea Completed
Phase 3 Mapracorat Ophthalmic Suspension for the Treatment of Ocular Inflammation Following Cataract Surgery Completed
Phase 3 Mapracorat Ophthalmic Suspension, 3% for the Treatment of Ocular Inflammation and Pain Following Cataract Surgery Completed
Phase 3 Study Evaluating the Safety of KetoNaph Ophthalmic Solution in Healthy Volunteers Completed
Phase 3 Ketotifen/Naphazoline Ophthalmic Solution in the Conjunctival Allergen Challenge Model of Acute Allergic Conjunctivitis. Completed
Phase 3 Ketotifen/Naphazoline Ophthalmic Solution in the Conjunctival Allergen Challenge Model of Allergic Conjunctivitis. Completed
Phase 3 Safety and Efficacy of KPI-121 in Subjects With DED Completed
Phase 3 A Single-Center Evaluation of the Relative Efficacy of EM-100 Compared to Zaditor® (Ketotifen Fumarate Ophthalmic Solution 0.035%) and Vehicle Completed
Phase 3 Safety & Efficacy WC3011 (Estradiol Vaginal Cream) in the Treatment of Vulvovaginal Atrophy in Postmenopausal Women Completed
Phase 3 Multicenter Study to Evaluate Safety and Efficacy of WC3011 (Estradiol Vaginal Cream) in Postmenopausal Women Completed
Phase 3 Study to Evaluate Safety and Efficacy of WC3011 (Estradiol Vaginal Cream) in Postmenopausal Women With Dyspareunia Completed
Phase 3 Study to Evaluate the Safety and Efficacy of a Once-Daily CLS001 Topical Gel Versus Vehicle Completed
Phase 3 Study to Evaluate the Safety and Efficacy of a Once-Daily CLS001 Topical Gel Versus Vehicle Completed
Phase 3 To Compare the Safety and Efficacy of Perrigo's Product to an FDA Approved Product for the Treatment of Secondarily Infected Traumatic Skin Lesions Completed
Phase 3 A Study to Assess Safety and Efficacy in Participants Age 40 to 55 With Presbyopia (Old Eye) Who Receive AGN-190584 in Both Eyes Twice Daily Completed
Phase 3 Safety and Efficacy Study of Sofpironium Bromide in Subjects With Axillary Hyperhidrosis (BBI-4000-CL-302) Completed
Phase 3 Safety and Efficacy Study of Sofpironium Bromide in Subjects With Axillary Hyperhidrosis (BBI-4000-CL-301) Completed
Phase 3 Evaluation of Brimonidine Tartrate/Ketotifen Fumarate Combination for the Treatment of Allergic Conjunctivitis Completed
Phase 3 An Evaluation of the Safety of CSF-1 in Presbyopic Subjects Completed
Phase 3 A Phase 3 Study Evaluating the Efficacy and Safety of OCS-01 Eyedrops Compared to Vehicle for the Treatment of Ocular Inflammation and Pain Following Cataract Surgery Completed
Phase 3 Phase 3 Efficacy Study of LNZ100 & LNZ101 for the Treatment of Presbyopia Completed
Phase 3 Phase 3 Safety Study of LNZ100 and LNZ101 for the Treatment of Presbyopia Subjects Completed
Phase 3 Study to Compare U0267 Against Vehicle in Subjects With Plaque-type Psoriasis One of Two Phase 3 Studies Completed
Phase 3 A Sequential Treatment Regimen of Cryotherapy and Picato® for the Treatment of Actinic Keratosis on the Face and Scalp Completed
Phase 3 Safety of Besivance™ (Besifloxacin Ophthalmic Suspension) 0.6% Compared to Vehicle Completed

Showing the 50 most-cited and recently-updated of 115 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.